Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Euvax B in HIV-infected adults
NCT02316444Phase 4Completed
- Sponsor
- Fred Hutchinson Cancer Center
- Start
- Nov 2015
- Primary completion
- Apr 2017
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, open-label trial of Hepatitis B vaccine in hepatitis B (HBV) (2 arms), sponsored by Fred Hutchinson Cancer Center. Primary endpoint: Hepatitis B virus (HBV) vaccine response at 18 months. Started Nov 2015; status: completed.
02
Drugs
Hepatitis B vaccine
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT02316444.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02316444.